Multi-targeted tyrosine kinase inhibitor sorafenib. Application experience in kidney cancer with lung metastases. Вопр. онкол. [Internet]. 2016 Dec. 15 [cited 2026 Oct. 14];62(1):154-6. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/240